| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/23/2001 | WO2001010554A3 Laboratory robot and method and reagent kit for isolating nucleic acids |
| 08/23/2001 | WO2001009341A3 Method of determining the activity of 1-deoxy-d-xylulose-5-phosphate reductoisomerase and 1-deoxy-d-xylulose-5-phosphate synthase |
| 08/23/2001 | WO2001009306A3 Mutant bacterial strains l-lysine production |
| 08/23/2001 | WO2001009300A3 Method for generating cgmmv resistant plants, genetic constructs, and obtained cgmmv-resistant plants |
| 08/23/2001 | WO2001009299A3 Modified plants |
| 08/23/2001 | WO2001009283A3 Chimeric receptors and their uses |
| 08/23/2001 | WO2001009175A3 Plant defensin variants with modified cystein residues |
| 08/23/2001 | WO2001007637A3 Conditionally controlled, attenuated HIV vaccine |
| 08/23/2001 | WO2001007631A3 Novel glycosyltransferase, the production thereof and its use |
| 08/23/2001 | WO2001007611A3 Novel polynucleotides and method for the use thereof |
| 08/23/2001 | WO2001007479A3 Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases |
| 08/23/2001 | WO2001006016A3 Amplification of nucleic acids with electronic detection |
| 08/23/2001 | WO2001004147A3 Plant inositol polyphosphate phosphatase homologs |
| 08/23/2001 | WO2001000860A3 Prolactin-inducible mammary specific promoter |
| 08/23/2001 | WO2001000842A3 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation |
| 08/23/2001 | WO2000078954A3 Human transcriptional regulator proteins |
| 08/23/2001 | WO2000078266A3 Interferon tau mutants and methods for making them |
| 08/23/2001 | WO2000077177A3 Isolation of a human retrovirus |
| 08/23/2001 | WO2000071668A3 Method for identifying components involved in signal transduction pathways in higher plants |
| 08/23/2001 | WO2000061737A3 Production of attenuated negative stranded RNA virus vaccines |
| 08/23/2001 | WO2000055325A3 Plant centromeres |
| 08/23/2001 | WO2000006738A3 NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 08/23/2001 | WO2000000615A3 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 08/23/2001 | WO1999064625A3 Methods and kits for discovery of rna-binding compounds |
| 08/23/2001 | WO1999047639A3 Staphylococcus aureus genes and polypeptides |
| 08/23/2001 | US20010016956 Introducing a DNA molecule into the plant cells whose growth is sensitive to inhibition by herbicides to which the protoporphyrinogen oxidase enzyme(protox) encoded by the DNA molecule is resistant, thus forming transformed plant cell |
| 08/23/2001 | US20010016955 Isolating mRNA from ripening blackcurrant fruit, preparing a cDNA library from isolated mRNA, differentially screening the library to identify gene expressed during ripening periiod and screening a genomic libray with pbrobes |
| 08/23/2001 | US20010016954 A nucleic acid comprising a promoter capable of directing expression predominantly in the roots of a plant, controls expression of a gene that does'nt respond to pathogenic infection and a sequence which encodes anti-nematode protein |
| 08/23/2001 | US20010016953 Expression of sucrose phosphorylase on plants |
| 08/23/2001 | US20010016952 Pathogenesis of cardiomyopathy |
| 08/23/2001 | US20010016951 A recombinant DNA construct comprising a polynucleotide encoding a human Amyloid precursor protein polypeptide comprising the Swedish mutation, functionally linked to a Thy-1 promoter element which is a rodent, e.g. mouse |
| 08/23/2001 | US20010016651 Enhancing the expression of down-regulated polynucleotides or introducing down-regulated polypeptide or protein to cell can decrease the growth and/or abnormal characteristics of cancer and dysplasia |
| 08/23/2001 | US20010016649 Nucleic acids and polypeptides; for diagnosing chondrosarcoma and for drug screening |
| 08/23/2001 | US20010016647 29 human secreted proteins |
| 08/23/2001 | US20010016645 Vitazin antibody; treating angiogenesis or restenosis |
| 08/23/2001 | US20010016644 Protein of given molecular weight and given N-terminal amino acid sequence |
| 08/23/2001 | US20010016598 Erythromycins and process for their preparation |
| 08/23/2001 | US20010016575 Antisense modulation of human MDM2 expression |
| 08/23/2001 | US20010016355 Genetic engineering |
| 08/23/2001 | US20010016354 Amplification of gene expression |
| 08/23/2001 | US20010016352 Oligonucleotides; detection cancer |
| 08/23/2001 | US20010016351 Genetic engineering |
| 08/23/2001 | US20010016350 Polynucleotides |
| 08/23/2001 | US20010016348 Immortal avian cells |
| 08/23/2001 | US20010016347 Packaging cell |
| 08/23/2001 | US20010016345 Apoptotic protease Mch6, nucleic acids encoding same and methods of use |
| 08/23/2001 | US20010016340 Antihemophilia agent |
| 08/23/2001 | US20010016339 Pancreatic polypeptide |
| 08/23/2001 | US20010016338 DNA molecule encoding a variant alpha2B-adrenoceptor protein, and uses thereof |
| 08/23/2001 | US20010016336 Genetic engineered polypeptide |
| 08/23/2001 | US20010016334 Polypeptide; screening for bactericides |
| 08/23/2001 | US20010016332 Genetic engineering |
| 08/23/2001 | US20010016320 Rapid-screen cDNA library panels |
| 08/23/2001 | US20010016319 Cloning of a novel G-protein coupled 7TM Receptor |
| 08/23/2001 | US20010016318 Methods for extrating similar expression patterns and related biopolymers |
| 08/23/2001 | US20010016316 Spatially addressable, cleavable reflective signal elements, assay device and method |
| 08/23/2001 | US20010016312 Low temperature storage |
| 08/23/2001 | US20010016200 Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor |
| 08/23/2001 | US20010016199 Alphavirus RNA replicon systems |
| 08/23/2001 | US20010016194 Compounds that inhibit the binding of raf-1 or 14-3-3 proteins to the beta chain of il-2 receptor, and pharmaceutical compositions containing same |
| 08/23/2001 | US20010016192 An expression vector of partial or total deletion of a protein DNA and a gene encoding a foreign protein; used as tumor suppressor genes |
| 08/23/2001 | US20010016191 Viewing informatoin, selecting a site for, and preparing a molecule of an alteration on a granulocyte colony-stimulating factor (g-csf) three dimensional molecule, and testing for desired characteristics; retain internal core helices |
| 08/23/2001 | EP1144681A3 Methods and kits for discovery of rna-binding compounds |
| 08/23/2001 | DE10007468A1 Neues zentralnervöses Protein, das K·+·-Ströme moduliert New central nervous protein that modulates K · · + currents |
| 08/23/2001 | DE10006886A1 Nichthumaner helferabhängiger Virusvektor A non-human helper-dependent virus vector |
| 08/23/2001 | DE10006662A1 Sample vessel for stabilizing and isolating nucleic acid, contains a lytic solution that stabilizes nucleic acid and a solid phase that binds it, especially for sampling whole blood |
| 08/23/2001 | DE10006591A1 Verfahren zur Aufreinigung von Nukleinsäuren A method for purifying nucleic acids |
| 08/23/2001 | DE10006590A1 Verwendung funktionalisierter,poröser Membranen zur Aufreinigung von Nukleinsäuren sowie entsprechende Verfahren Use of functionalized porous membranes for purification of nucleic acids and corresponding methods |
| 08/23/2001 | DE10006309A1 Verfahren zur Identifizierung von Substanzen, die die Aktivität von hyperpolarisationsaktivierten Kationen-kanälen modulieren A method for identifying substances that modulate the activity of hyperpolarization-activated cation channels, |
| 08/23/2001 | DE10004468A1 Allenoxidcyclasegen und dessen Verwendung zum Herstellen von Jasmonsäure Allenoxidcyclasegen and its use for the production of jasmonic acid |
| 08/23/2001 | CA2402440A1 Aids ancestral viruses and vaccines |
| 08/23/2001 | CA2402148A1 Novel sphingosine kinases |
| 08/23/2001 | CA2400981A1 Novel proteins and novel genes encoding the same |
| 08/23/2001 | CA2400785A1 Novel human kinases and polynucleotides encoding the same |
| 08/23/2001 | CA2400706A1 Genetically engineered skin cell types and toxicity assays |
| 08/23/2001 | CA2400588A1 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 08/23/2001 | CA2400473A1 Her-2 binding antagonists |
| 08/23/2001 | CA2400384A1 Methods and kits for proximity probing |
| 08/23/2001 | CA2400379A1 Microarray methods utilizing semiconductor nanocrystals |
| 08/23/2001 | CA2400367A1 Reduction of in planta degradation of recombinant plant products |
| 08/23/2001 | CA2400360A1 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | CA2400342A1 Transgenic animal model for obesity expressing foxc2 |
| 08/23/2001 | CA2400332A1 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | CA2400328A1 Methods for identifying agents that cause a lethal phenotype, and agents thereof |
| 08/23/2001 | CA2400263A1 Method of controlling telomere length |
| 08/23/2001 | CA2400256A1 Compositions useful for regulating parkin gene activity |
| 08/23/2001 | CA2400207A1 Multiple-site reaction device and method |
| 08/23/2001 | CA2400110A1 Method for increasing the gene expression of transfected genes using carnitine |
| 08/23/2001 | CA2400101A1 Human protein tyrosine phosphatase, encoding dna and uses thereof |
| 08/23/2001 | CA2400087A1 Altered recombinases for genome modification |
| 08/23/2001 | CA2400034A1 Human kinases |
| 08/23/2001 | CA2400028A1 Libraries of optimum subsequence regions of mrna and genomic dna for control of gene expression |
| 08/23/2001 | CA2399990A1 Container for nucleic acid analysis |
| 08/23/2001 | CA2399705A1 Treatment for bone disorders |
| 08/23/2001 | CA2399163A1 Composite membranes for assaying biomolecules |
| 08/23/2001 | CA2399137A1 Alteration of growth and adaptation under hypoxic conditions |
| 08/23/2001 | CA2398999A1 Compositions and methods for surface imprinting |
| 08/23/2001 | CA2398945A1 Small oligonucleotides with anti-tumor activity |
| 08/23/2001 | CA2398872A1 Avirulent, immunogenic flavivirus chimeras |
| 08/23/2001 | CA2398861A1 Gene disruption methodologies for drug target discovery |